Related Experiment Videos
Modification of hepatic genomic DNA using RNA/DNA oligonucleotides
1Department of Medicine, University of Minnesota, Minneapolis, MN 55108, USA.
Gene Therapy
|May 29, 2002
Summary
Gene therapy using chimeraplasty precisely corrects genetic mutations in liver cells and mitochondria. This in situ DNA repair strategy offers stable, long-term correction of genetic defects.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Gene therapy aims for precise genetic defect repair without off-target modifications.
- Chimeraplasty, utilizing RNA/DNA oligonucleotides, offers a strategy for in situ genomic repair.
Purpose of the Study:
- To develop and assess chimeraplasty for precise in situ correction of single nucleotide mutations in vivo.
- To investigate the potential for chimeraplasty to repair mitochondrial DNA defects.
Main Methods:
- In vivo delivery of chimeraplasts to rat hepatocytes via the asialoglycoprotein receptor.
- In vitro DNA repair assays using mutagenized plasmids and an Escherichia coli readout system.
- Analysis of mitochondrial extracts for enzymatic activity in DNA repair.
Main Results:
- Successful and stable modification of hepatic genes and phenotypes in rats for 2 years using chimeraplasty.
- Mitochondrial extracts demonstrated enzymatic activity for precise single-nucleotide changes, similar to nuclear extracts.
- Single-stranded oligonucleotides promoted gene conversion in both mitochondrial and nuclear extracts.
Conclusions:
- Chimeraplasty is an effective strategy for stable, in situ correction of nuclear gene mutations.
- Mitochondria possess enzymatic machinery capable of mediating chimeraplast-based DNA repair.
- Oligonucleotide-mediated gene repair presents a promising approach for precise genetic mutation correction.